Latest Breaking News On - Pfizer of biohaven pharmaceutical holding company ltd - Page 1 : comparemela.com

Acquired exclusive license for oral, brain-penetrant, dual TYK2/JAK1 inhibitor for immune-mediated brain disorders in March 2023 covering global (ex-China).

United statesDana farber cancer instituteUnited kingdomMike beyerJennifer porcelliMatthew butenIrfan qureshiTanya fischerBiohaven therapeutics ltdHealth canadaPfizer incUnited states distribution services agreementDevelopment rd expensesPfizer of biohaven pharmaceutical holding company ltdChannel biosciencesBiohaven pharmaceutical holding company ltd